AstraZeneca India to Protest $1.4 Million Transfer Pricing Order

Pharmaceutical company AstraZeneca Pharma India Ltd. will challenge a nearly $1.4 million transfer pricing adjustment proposed by the country’s tax authorities.

AstraZeneca said it received an order from the Indian tax authority’s transfer pricing officer Jan. 6 proposing adjustments for assessment year 2022-2023 totaling 119.6 million rupees ($1.4 million) not including any interest or penalties, according to a filing from the company Tuesday.

AstraZeneca said it will challenge the assessment.

• The dispute is the latest for the company that has challenged a number of adjustments in India’s tax courts, recently winning one case.
• In November, the Income Tax Appellate ...